Lipoprotein (a), Inflammation, and Atherosclerosis

Lipoprotein (a), Inflammation, and Atherosclerosis

Growing evidence has shown that high levels of lipoprotein (a) (Lp(a)) and chronic inflammation may be responsible for the residual risk of cardiovascular events in patients managed with an optimal evidence-based approach. Clinical studies have demonstrated a correlation between higher Lp(a) levels...

Full description

Bibliographic Details
Main Authors: Stefania Angela Di Fusco, Aldo Pietro Maggioni, Pietro Scicchitano, Marco Zuin, Emilia D’Elia, Furio Colivicchi
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Journal of Clinical Medicine
Subjects:
lipoprotein (a)
cardiovascular prevention
inflammation
colchicine
personalized medicine
Online Access:https://www.mdpi.com/2077-0383/12/7/2529

Internet

https://www.mdpi.com/2077-0383/12/7/2529

Similar Items